Solara Active Pharma Releases FY26 BRSR Report

Solara Active Pharma Sciences Ltd has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, as per SEBI regulations. The report details the company's corporate identity, registered and corporate addresses, financial year reporting period, and stock exchange listings (BSE and NSE). It outlines the company's business activities, primarily focusing on the design and manufacture of Active Pharmaceutical Ingredients (APIs), which account for 100% of its turnover. The report also covers operational details, including 10 locations (6 manufacturing, 2 offices, 1 R&D center), markets served nationally and internationally, and export contribution (52% of turnover). Employee data for FY25-26 is provided, showing a total of 1032 employees and 2076 workers, with specific figures for male and female staff. The report confirms standalone reporting and does not have an assurance provider.